Announced Thu, 11 Dec, 2025 · 11:30 IST
Vivimed Labs trading resumes Dec 18 after suspension revoked by BSE and NSE
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction
Awaiting price reaction for this filing.
AI summary
Vivimed Labs (BSE: 532660, NSE: VIVIMEDLAB) informs that BSE and NSE have revoked the suspension on trading its equity shares. Trading will resume from December 18, 2025. On BSE, the stock moves to T group; on NSE, it will be in Trade-for-Trade (BE series). A special pre-open relist session is scheduled for December 18. The company says it has now complied with prior SEBI LODR non-compliances that had led to the suspension.
Likely market impact
Liquidity and price discovery return for shareholders. Expect sharp moves and volatility on first trading day as the relisted scrip finds a fair price.